![Kenneth Kelley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kenneth Kelley
Vorstandsvorsitzender bei
IDBiologics, Inc.
Profil
Kenneth J. Kelley ist ein Geschäftsmann, der IntraBiotics Pharmaceuticals, Inc. und Emergent Travel Health, Inc. gegründet hat und an der Spitze von 7 verschiedenen Unternehmen stand. Gegenwärtig ist er Vorsitzender von Seromyx Systems, Inc. und Vorsitzender von Selva Therapeutics, Inc. Herr Kelley ist auch im Vorstand von Halozyme Therapeutics, Inc. (ehemaliger Vorsitzender), Meissa Vaccines, Inc., Actym Therapeutics, Inc. und IDBiologics, Inc. sowie Geschäftsführer bei K2 BioVentures LLC. In seiner früheren Laufbahn war Kenneth J. Kelley Direktor bei Solus Biosystems, Inc, Chairman von Fluxion Biosciences, Inc, General Partner bei Latterell Venture Partners, Associate bei Institutional Venture Partners, Berater bei McKinsey & Co, Inc, Chairman & Chief Executive Officer bei IntraBiotics Pharmaceuticals, Inc, Director bei Emergent Travel Health, Inc. und Wissenschaftler bei Integrated Genetics, Inc. Kenneth J. Kelley erhielt einen Undergraduate-Abschluss der Harvard University und einen MBA der Stanford University.
Aktive Positionen von Kenneth Kelley
| Unternehmen | Position | Beginn |
|---|---|---|
K2 BioVentures LLC | Corporate Officer/Principal | 07.07.2010 |
Meissa Vaccines, Inc.
 Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus | Direktor/Vorstandsmitglied | 27.03.2019 |
Actym Therapeutics, Inc.
 Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Direktor/Vorstandsmitglied | - |
IDBiologics, Inc.
 IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases | Vorstandsvorsitzender | 01.01.2017 |
Seromyx Systems, Inc.
 Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics | Vorsitzender | - |
Selva Therapeutics, Inc.
 Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases | Vorsitzender | - |
Ehemalige bekannte Positionen von Kenneth Kelley
| Unternehmen | Position | Ende |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Vorsitzender | 01.01.2015 |
Latterell Venture Partners
 Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Corporate Officer/Principal | 01.06.2004 |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Direktor/Vorstandsmitglied | - |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Kenneth Kelley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
51
Beziehungen ersten Grades
19
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 19 |
|---|---|
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Halozyme Therapeutics, Inc.
 Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
Latterell Venture Partners
Latterell Venture Partners Investment ManagersFinance Latterell Venture Partners invests in companies located in the United States. The firm focuses on biotechnology, research instrument, biomaterial, medical device and diagnostic ventures, pharmaceutical sectors. It provides financing for early stage capital requirements with an investment size of USD 0.05 - 10 million. It makes co-investments and also acts as a lead investor. It takes seat on the board of directors. | Finance |
Solus Biosystems, Inc.
 Solus Biosystems, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops tools for measurement of changes in protein conformation | Electronic Technology |
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Creates solutions to health threats | Commercial Services |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. BiotechnologyHealth Technology Provides biotechnical research services | Health Technology |
Fluxion Biosciences, Inc.
 Fluxion Biosciences, Inc. Information Technology ServicesTechnology Services Provides automated patch clamp technology and cell-based assay tools | Technology Services |
Institutional Venture Partners
 Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners invests in companies located in North America and Europe. The firm focuses on a broad range of sectors. It provides financing for growth stage capital requirements with the investment size of USD 15 - 75 millions. It also participates in follow on investments. | Finance |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MPEX Pharmaceuticals, Inc.
 MPEX Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops therapies for antibiotic resistance | Commercial Services |
Integrated Genetics, Inc.
 Integrated Genetics, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceuticals preparations | Health Technology |
K2 BioVentures LLC | |
Meissa Vaccines, Inc.
Meissa Vaccines, Inc. BiotechnologyHealth Technology Develops vaccines for respiratory syncytial virus and rhinovirus | Health Technology |
Actym Therapeutics, Inc.
Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immune-oncology therapies | Health Technology |
Seromyx Systems, Inc.
Seromyx Systems, Inc. Pharmaceuticals: MajorHealth Technology Develop immune vaccines, immunotherapies, drugs and diagnostics | Health Technology |
IDBiologics, Inc.
IDBiologics, Inc. BiotechnologyHealth Technology Develops human monoclonal antibodies for the prevention, treatment and cure of infectious diseases | Health Technology |
Selva Therapeutics, Inc.
Selva Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company dedicated to development of therapeutics for infectious diseases | Health Technology |
Wählen Sie MarketScreener 
